Best-selling in Textbooks
Save on Textbooks
- AU $27.54Trending at AU $44.05
- AU $80.99Trending at AU $88.14
- AU $72.90Trending at AU $77.73
- AU $71.88Trending at AU $73.43
- AU $82.90Trending at AU $85.64
- AU $72.90Trending at AU $79.61
- AU $34.73Trending at AU $42.75
About this product
- DescriptionStreptozotocin (STZ), an antibiotic and anticancer agent, is the most prominent diabetogenic chemical agent in diabetes research due to its cytotoxicity in pancreatic beta-cells. The selective toxicity of STZ to beta cells occurs because of its preferential accumulation in beta cells through uptake via GLUT2 glucose transporter. Insulin dependent diabetes mellitus can be induced by either single high dose or multiple low-dose STZ injections. At low dose, STZ induces pancreatic beta-cell apoptosis and at high dose it causes necrosis. Though STZ itself can cause carcigenesis and renal, hepatic and muscle myoblast toxicity, these side effects can be minimised or completely avoided by using lower doses. This book discusses in further detail the different ways in which streptozotocin is used in the medical field.
- PublisherNova Science Publishers Inc
- Date of Publication22/05/2014
- SubjectClinical Medicine: Professional
- Place of PublicationNew York
- Country of PublicationUnited States
- ImprintNova Science Publishers Inc
- Weight466 g
- Width180 mm
- Height260 mm
- Spine14 mm
- Edited byElizabeth L Gauthier
This item doesn't belong on this page.
Thanks, we'll look into this.